RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 36.18M | 83.06M | 125.10M | |
| R&D | 28.00M | 60.94M | 94.79M | |
| SG&A | 8.18M | 22.12M | 30.31M | |
| Operating Income | -36.18M | -83.06M | -125.10M | |
| EBITDA | -36.07M | -82.22M | -124.08M | |
| Pretax Income | -34.78M | -78.31M | -111.48M | |
| Income Tax | 10.00K | 0.00 | -- | |
| Net Income | -34.79M | -78.31M | -111.48M | |
| EPS Diluted | -23.10 | -3.78 | -2.86 | |
| Diluted Shares | 1.51M | 20.74M | 38.93M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--